ClinicalTrials.Veeva

Menu

Mindfulness-based Cognitive Therapy for the Chronic Pain-early Cognitive Decline Co-morbidity Among Older Black Individuals in the Community; The Feeling of Being Open Pilot

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Early Cognitive Decline
Chronic Pain

Treatments

Behavioral: Quiet Focus

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07210398
2024P002081
UM1TR004408 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The goal of this clinical trial is to pilot an adaptation of mindfulness-based cognitive therapy for chronic pain and early cognitive decline. The main questions it aims to answer in a later fully powered randomized controlled trial are:

  • Is an adaptation of mindfulness-based cognitive therapy for older Black adults able to improve quality of life?
  • Will an adapted mindfulness based cognitive therapy reduce pain interference to a greater degree than a traditional health enhancement program?

Full description

Co-morbid chronic pain and early cognitive decline is common among older Black adults and this co-morbidity worsens physical and cognitive function. Access to evidence based non-pharmacological management is limited. Mindfulness based cognitive therapy (MBCT) is an evidence-based, non-pharmacological intervention that could address the chronic pain and early cognitive decline co-morbidity among older Black adults, but it requires tailoring. The proposed study will establish the feasibility, acceptability and credibility of Feeling of Being, a cultural adaptation of MBCT aimed at the chronic pain and early cognitive decline co-morbidity among older Black adults in the community.

Enrollment

9 patients

Sex

All

Ages

50 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Older adult (age ≥ 50)
  • All individuals who identify with one or more nationalities or ethnic groups originating in any of the Black racial groups of Africa
  • Pain in muscles, joints, bones, or associated soft tissues (NRS>4) lasting longer than 3 months
  • Early Cognitive Decline (subjective or MCI)
  • Telephone Interview for Cognitive Status-41 score ≥ 26
  • Functional Activities Questionnaire score < 9
  • English fluency/literacy
  • Ability and willingness to participate via in-person and video
  • Willing to provide informed consent and comply with all aspects of the protocol

Exclusion criteria

  • Current substance abuse/dependence
  • Significant cognitive impairment
  • History of more than 8 sessions of cognitive-behavioral therapy
  • History of previous training in mindfulness or undergoing counseling more than once a month
  • History of or current diagnosis of psychosis
  • Active suicidal ideation or self-harm within the past 90 days

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

9 participants in 1 patient group

Feeling of Being
Experimental group
Treatment:
Behavioral: Quiet Focus

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems